The deregulation of PLC signaling is associated with many brain diseases such as Alzheimer’s Disease (AD), Huntington’s Disease (HD), Epilepsy, Schizophrenia, Bipolar disorder, and Depression (Yang et al., 2016). This evidence concerns the gene HSPG2 and schizophrenia.